ubidecarenone 20 MG/ML / vitamin E 0.2 UNT/ML Oral Solution

RxCUI
1088926
RxNorm name
ubidecarenone 20 MG/ML / vitamin E 0.2 UNT/ML Oral Solution
Display name
Ubidecarenone/Vitamin E (Oral Liquid)
Full name
ubidecarenone 20 MG/ML / vitamin E 0.2 UNT/ML Oral Solution
Term type
SCD
Status
Active
Strength
100-1 var units/5ml
Dose form
Sol
Route
Oral Liquid
Updated
2026-07-15 00:15:20

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
032011
Active start
032011
Multiple ingredient
YES
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
vitamin E0.2 UNT / 1 MLvitamin Evitamin E
ubidecarenone20 MG / 1 MLubidecarenoneubidecarenone

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Oral Solution316968

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
vitamin E11256
ubidecarenone21406

Source Vocabulary Codes#

Code type, Value, Category table
Code typeValueCategory
PRESCRIBABLEYATTRIBUTES
RXNAV_STRubidecarenone 20 MG/ML / vitamin E 0.2 UNT/ML Oral SolutionNAMES
RxNorm Nameubidecarenone 20 MG/ML / vitamin E 0.2 UNT/ML Oral SolutionNAMES
RxNorm Synonymcoenzyme Q10 100 MG / vitamin E 1 UNT per 5 ML Oral SolutionNAMES
TTYSCDATTRIBUTES
RxCUI1088926CODES

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCC01EBOther cardiac preparationsATC1-4ubidecarenone
ATCA11HAOther plain vitamin preparationsATC1-4vitamin E
MEDRTD014451UbiquinoneCHEMhas_ingredientubidecarenone
MEDRTD014810Vitamin ECHEMhas_ingredientvitamin E
MEDRTD000544Alzheimer DiseaseDISEASEmay_preventvitamin E
MEDRTD000544Alzheimer DiseaseDISEASEmay_treatvitamin E
MEDRTD000743Anemia, HemolyticDISEASEmay_preventvitamin E
MEDRTD000743Anemia, HemolyticDISEASEmay_treatvitamin E
MEDRTD000787Angina PectorisDISEASEmay_treatubidecarenone
MEDRTD001997Bronchopulmonary DysplasiaDISEASEmay_preventvitamin E
MEDRTD004342Drug HypersensitivityDISEASEci_withvitamin E
MEDRTD004342Drug HypersensitivityDISEASEci_withubidecarenone
MEDRTD064420Drug-Related Side Effects and Adverse ReactionsDISEASEmay_preventubidecarenone
MEDRTD004409Dyskinesia, Drug-InducedDISEASEmay_preventvitamin E
MEDRTD004409Dyskinesia, Drug-InducedDISEASEmay_treatvitamin E
MEDRTD015673Fatigue Syndrome, ChronicDISEASEmay_treatubidecarenone
MEDRTD006333Heart FailureDISEASEmay_treatubidecarenone
MEDRTD006816Huntington DiseaseDISEASEmay_treatubidecarenone
MEDRTD006949HyperlipidemiasDISEASEmay_treatubidecarenone
MEDRTD006973HypertensionDISEASEmay_treatubidecarenone
MEDRTD014811Vitamin E DeficiencyDISEASEmay_treatvitamin E
MEDRTD014811Vitamin E DeficiencyDISEASEmay_preventvitamin E
MEDRTN0000000163Enzyme InteractionsMOAhas_moaubidecarenone
MEDRTN0000000170Free Radical Scavenging ActivityMOAhas_moavitamin E
MEDRTN0000009934Decreased Vitamin Uptake and ModificationPEhas_pevitamin E
MEDRTN0000009925Unknown Physiological EffectPEhas_peubidecarenone

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH20 MG/ML / 0.2 UNT/ML
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESPRESCRIBABLEY
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESTTYSCD
CODESRxCUI1088926
NAMESRXNAV_STRubidecarenone 20 MG/ML / vitamin E 0.2 UNT/ML Oral Solution
NAMESRxNorm Nameubidecarenone 20 MG/ML / vitamin E 0.2 UNT/ML Oral Solution
NAMESRxNorm Synonymcoenzyme Q10 100 MG / vitamin E 1 UNT per 5 ML Oral Solution
SOURCESSourceNational Drug Data File Plus Source Vocabulary